USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $-0.45 | $-0.48 | $-0.58 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $0.00 | $0.00 | $0.00 |
Aprea Therapeutics, Inc's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $-0.40 | $-0.47 | $-0.32 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $-1.73 | $-1.88 | $-1.54 |
| Dec 2022 | 5 | $-1.63 | $-2.09 | $-1.25 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.40 | $-0.41 | $-0.41 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-1.73 | $-1.74 | $-1.74 |
| Dec 2022 | 0 / 0 | $-1.63 | $-1.60 | $-1.60 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $0.00 | $0.00 | $0.00 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $0.00 | $0.00 | $0.00 |
| Dec 2022 | 5 | $0.00 | $0.00 | $0.00 |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $-0.45 | - | - |
| Aug 12, 2021 | Jun 2021 | $-0.47 | $-0.48 | -2.43% |
| May 6, 2021 | Mar 2021 | $-0.49 | $-0.46 | 6.50% |
| Mar 16, 2021 | Dec 2020 | $-0.64 | $-0.73 | -13.71% |
| Nov 5, 2020 | Sep 2020 | $-0.76 | $-0.58 | 23.73% |
| Aug 11, 2020 | Jun 2020 | $-0.60 | $-0.78 | -29.46% |
| May 15, 2020 | Mar 2020 | $-0.57 | $-0.45 | 20.70% |
| Mar 26, 2020 | Dec 2019 | $-0.41 | $-0.64 | -56.06% |
| Nov 14, 2019 | Sep 2019 | $-5.67 | $-5.29 | 6.76% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 16, 2021 | Dec 2020 | $-2.43 | $-2.54 | - |
| Mar 26, 2020 | Dec 2019 | $-2.87 | $-5.93 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 3, 2021 | Sep 2021 | $0.00 | - | - |
| Aug 12, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 6, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Mar 16, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Nov 5, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Aug 11, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| May 15, 2020 | Mar 2020 | $0.00 | $0.00 | - |
| Mar 26, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Nov 14, 2019 | Sep 2019 | $0.00 | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 16, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Mar 26, 2020 | Dec 2019 | $0.00 | $0.00 | - |
APRE's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 4 analysts, the average EPS estimation for Aprea Therapeutics, Inc's next quarterly earnings is $-0.45, with a low EPS estimation of $-0.49, and a high estimation of $-0.40.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.45, the last 2 month trend is $-0.47, and the 3 month trend is $-0.47.
Based on 3 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.
Aprea Therapeutics, Inc's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.
APRE's earnings per share (EPS) was $-0.48, missing the consensus analysts forecast of $-0.47 by -2.43%.
The EPS was lower than the previous fiscal quarter (Mar 2021) by 4.35%, and higher than the same period a year before (Jun 2020) by -38.46%.
Revenues were $0.00.
The company reported a net income of $-10.25M.Free cash flow for the quarter was $-7.75M , compared to $-11.52M last quarter and $-9.64M a year before.
APRE ended the quarter with $199.22K in total debt, a decrease of -23.17% compared to the previous quarter, and a decrease of -53.39% compared to the same quarter a year before.
Aprea Therapeutics, Inc's previous annual earnings date was Mar 16, 2021 for its fiscal year ended Dec 31, 2020.
APRE's earnings per share (EPS) was $-2.54, missing the consensus analysts forecast of $-2.43 by 4.53% , and higher than the previous year's EPS (Dec 2019) by -57.17%.
Revenues were $0.00.
The company reported a net income of $-53.48M.
Aprea Therapeutics, Inc reported a free cash flow of $-41.83M for its fiscal year, compared to $-26.74M a year ago.
The company ended the fiscal year with $335.16K in total debt, a decrease of -38.50% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.